US 8648037
Macrocyclic proline derived HCV serine protease inhibitors
granted A61KA61K38/00A61K38/12
Quick answer
US patent 8648037 (Macrocyclic proline derived HCV serine protease inhibitors) held by Enanta Pharmaceuticals, Inc. expires Mon Feb 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Feb 11 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 06 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61K, A61K38/00, A61K38/12, A61K38/212, A61K38/215